MINDY FARMER: Open Payments
NPI 1386601011 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 85 payments from 18 companies in 2025. Trend: 2023 $980 · 2024 $776 · 2025 $1,386
Food & beverage: $1,370Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $226 |
| Novo Nordisk Inc | 12 | $186 |
| PFIZER INC. | 12 | $172 |
| Lilly USA, LLC | 12 | $155 |
| ABBVIE INC. | 11 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $131 |
| Dexcom, Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
Products named: XIFAXAN, MOUNJARO, BREZTRI, Dexcom G6 Transmitter, Wegovy, FARXIGA, Rybelsus, QULIPTA.
Industry payments across AR — which companies pay providers there.
